Urolithin D is a competitive and selective reversible antagonist of the EphA receptor, an ellagitannin colonic metabolite that inhibits EphA2 phosphorylation in prostate cancer cells, attenuates triglyceride accumulation in adipocytes and hepatocyte cultures, and may be used in the study of metabolic disorders.
Molekulargewicht:
260.2
Reinheit:
99.87%
CAS Nummer:
[131086-98-1]
Formel:
C13H8O6
Target-Kategorie:
PPAR|||Ephrin Receptor|||AMPK
T74005
T74005
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten